Nonclinical Assessment of Abuse Potential for New Pharmaceuticals

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Reference & Language, Law, International
Cover of the book Nonclinical Assessment of Abuse Potential for New Pharmaceuticals by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780124202160
Publisher: Elsevier Science Publication: July 14, 2015
Imprint: Academic Press Language: English
Author:
ISBN: 9780124202160
Publisher: Elsevier Science
Publication: July 14, 2015
Imprint: Academic Press
Language: English

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

  • Provides a consolidated overview of the complex regulatory landscape
  • Offers best practice methodology for conducting animal studies, including selection of doses and positive control agents that will help you improve your own abuse potential studies
  • Includes real-life examples to illustrate how nonclinical data fit into the submission strategy
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug.  By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.

More books from Elsevier Science

Cover of the book EMC at Component and PCB Level by
Cover of the book Thermomechanical Behavior of Dissipative Composite Materials by
Cover of the book Kappa Distributions by
Cover of the book Molecular Biology of Aging by
Cover of the book Handbook of Membrane Reactors by
Cover of the book Characterization of Nanomaterials in Complex Environmental and Biological Media by
Cover of the book Inhaled Pharmaceutical Product Development Perspectives by
Cover of the book Bond and Money Markets: Strategy, Trading, Analysis by
Cover of the book Microforming Technology by
Cover of the book The Encyclopedia of Volcanoes by
Cover of the book Principles of Project Finance by
Cover of the book The Basics of Digital Forensics by
Cover of the book Identifying and Addressing the Social Issues Experienced by Individuals with IDD by
Cover of the book High-Rise Security and Fire Life Safety by
Cover of the book Handbook of Solid-State Lasers by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy